Global Biologics CDMO Services Market Growth (Status and Outlook) 2026-2032
The global Biologics CDMO Services market size is predicted to grow from US$ 30800 million in 2025 to US$ 74150 million in 2032; it is expected to grow at a CAGR of 13.6% from 2026 to 2032.
Biologics CDMO Services refer to the specialized contract development and manufacturing services provided by a Contract Development and Manufacturing Organization (CDMO) for biologic drugs. Biologics are complex medicines made from living cells or organisms, such as proteins, monoclonal antibodies, vaccines, and cell or gene therapies.
Increasing Demand for Biologics: The rising demand for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, is a significant driver. Biologics are increasingly becoming a focus for drug development due to their effectiveness in treating various diseases.
Cost-Effective Outsourcing: Outsourcing to CDMOs allows pharmaceutical and biotech companies to reduce capital expenditures, mitigate risks, and achieve cost savings. CDMOs offer specialized facilities and expertise, allowing clients to avoid the need for extensive in-house infrastructure.
Strategic Partnerships and Collaborations: Pharmaceutical and biotech companies increasingly engage in strategic partnerships with CDMOs to access specialized capabilities, share development risks, and benefit from the CDMO's expertise in specific technologies or therapeutic areas.
To meet the growing demand for biopharmaceuticals, CDMOs are investing in expanding their biomanufacturing capacities. This includes the construction of new facilities and the acquisition of advanced technologies to increase production capabilities.
The increasing interest and investment in cell and gene therapies have led to a rise in demand for CDMOs offering services in this area. Companies are seeking expertise in cell line development, viral vector production, and other specialized services related to advanced therapies.
Biologics CDMOs are expanding their global presence to cater to the needs of a geographically diverse client base. This includes establishing facilities in key regions and forming strategic partnerships to enhance their global reach.
CDMOs are expanding their service offerings to provide integrated solutions covering the entire biopharmaceutical development and manufacturing lifecycle. This integrated approach aims to streamline processes and accelerate time to market for clients.
LPI (LP Information)' newest research report, the ?Biologics CDMO Services Industry Forecast? looks at past sales and reviews total world Biologics CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics CDMO Services sales for 2026 through 2032. With Biologics CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Biologics CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biologics CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biologics CDMO Services refer to the specialized contract development and manufacturing services provided by a Contract Development and Manufacturing Organization (CDMO) for biologic drugs. Biologics are complex medicines made from living cells or organisms, such as proteins, monoclonal antibodies, vaccines, and cell or gene therapies.
Increasing Demand for Biologics: The rising demand for biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, is a significant driver. Biologics are increasingly becoming a focus for drug development due to their effectiveness in treating various diseases.
Cost-Effective Outsourcing: Outsourcing to CDMOs allows pharmaceutical and biotech companies to reduce capital expenditures, mitigate risks, and achieve cost savings. CDMOs offer specialized facilities and expertise, allowing clients to avoid the need for extensive in-house infrastructure.
Strategic Partnerships and Collaborations: Pharmaceutical and biotech companies increasingly engage in strategic partnerships with CDMOs to access specialized capabilities, share development risks, and benefit from the CDMO's expertise in specific technologies or therapeutic areas.
To meet the growing demand for biopharmaceuticals, CDMOs are investing in expanding their biomanufacturing capacities. This includes the construction of new facilities and the acquisition of advanced technologies to increase production capabilities.
The increasing interest and investment in cell and gene therapies have led to a rise in demand for CDMOs offering services in this area. Companies are seeking expertise in cell line development, viral vector production, and other specialized services related to advanced therapies.
Biologics CDMOs are expanding their global presence to cater to the needs of a geographically diverse client base. This includes establishing facilities in key regions and forming strategic partnerships to enhance their global reach.
CDMOs are expanding their service offerings to provide integrated solutions covering the entire biopharmaceutical development and manufacturing lifecycle. This integrated approach aims to streamline processes and accelerate time to market for clients.
LPI (LP Information)' newest research report, the ?Biologics CDMO Services Industry Forecast? looks at past sales and reviews total world Biologics CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biologics CDMO Services sales for 2026 through 2032. With Biologics CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Biologics CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biologics CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- WuXi Biologics
- Recipharm
- Thermo Fisher Scientific
- AGC Biologics
- Rentschler Biopharma
- KBI Biopharma
- Siegfried
- Aenova Group
- GenScript
- ProBioGen
- Northway Biotech
- 3P Biopharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CDMO Services Market Size (2021-2032)
2.1.2 Biologics CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biologics CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Biologics CDMO Services Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.2.5 Biologics CDMO Services Market Size by Type
2.2.5.1 Biologics CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biologics CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Biologics CDMO Services Segment by Application
2.3.1 SMBs
2.3.2 Large Companies
2.3.3 Biologics CDMO Services Market Size by Application
2.3.3.1 Biologics CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Biologics CDMO Services Market Size Market Share by Application (2021-2026)
3 BIOLOGICS CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Biologics CDMO Services Market Size Market Share by Player
3.1.1 Global Biologics CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Biologics CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Biologics CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS CDMO SERVICES BY REGION
4.1 Biologics CDMO Services Market Size by Region (2021-2026)
4.2 Global Biologics CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics CDMO Services Market Size Growth (2021-2026)
4.4 APAC Biologics CDMO Services Market Size Growth (2021-2026)
4.5 Europe Biologics CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biologics CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biologics CDMO Services Market Size by Country (2021-2026)
5.2 Americas Biologics CDMO Services Market Size by Type (2021-2026)
5.3 Americas Biologics CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CDMO Services Market Size by Region (2021-2026)
6.2 APAC Biologics CDMO Services Market Size by Type (2021-2026)
6.3 APAC Biologics CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics CDMO Services Market Size by Country (2021-2026)
7.2 Europe Biologics CDMO Services Market Size by Type (2021-2026)
7.3 Europe Biologics CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Biologics CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biologics CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS CDMO SERVICES MARKET FORECAST
10.1 Global Biologics CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Biologics CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Biologics CDMO Services Forecast
10.1.3 APAC Biologics CDMO Services Forecast
10.1.4 Europe Biologics CDMO Services Forecast
10.1.5 Middle East & Africa Biologics CDMO Services Forecast
10.2 Americas Biologics CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Biologics CDMO Services Forecast
10.2.2 Canada Market Biologics CDMO Services Forecast
10.2.3 Mexico Market Biologics CDMO Services Forecast
10.2.4 Brazil Market Biologics CDMO Services Forecast
10.3 APAC Biologics CDMO Services Forecast by Region (2027-2032)
10.3.1 China Biologics CDMO Services Market Forecast
10.3.2 Japan Market Biologics CDMO Services Forecast
10.3.3 Korea Market Biologics CDMO Services Forecast
10.3.4 Southeast Asia Market Biologics CDMO Services Forecast
10.3.5 India Market Biologics CDMO Services Forecast
10.3.6 Australia Market Biologics CDMO Services Forecast
10.4 Europe Biologics CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biologics CDMO Services Forecast
10.4.2 France Market Biologics CDMO Services Forecast
10.4.3 UK Market Biologics CDMO Services Forecast
10.4.4 Italy Market Biologics CDMO Services Forecast
10.4.5 Russia Market Biologics CDMO Services Forecast
10.5 Middle East & Africa Biologics CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biologics CDMO Services Forecast
10.5.2 South Africa Market Biologics CDMO Services Forecast
10.5.3 Israel Market Biologics CDMO Services Forecast
10.5.4 Turkey Market Biologics CDMO Services Forecast
10.6 Global Biologics CDMO Services Forecast by Type (2027-2032)
10.7 Global Biologics CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biologics CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biologics CDMO Services Product Offered
11.1.3 Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biologics CDMO Services Product Offered
11.2.3 Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biologics CDMO Services Product Offered
11.3.3 Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biologics CDMO Services Product Offered
11.5.3 Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Biologics CDMO Services Product Offered
11.6.3 WuXi Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biologics CDMO Services Product Offered
11.7.3 Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biologics CDMO Services Product Offered
11.8.3 Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biologics CDMO Services Product Offered
11.9.3 AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biologics CDMO Services Product Offered
11.10.3 Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biologics CDMO Services Product Offered
11.11.3 KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biologics CDMO Services Product Offered
11.12.3 Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biologics CDMO Services Product Offered
11.13.3 Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biologics CDMO Services Product Offered
11.14.3 GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biologics CDMO Services Product Offered
11.15.3 ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biologics CDMO Services Product Offered
11.16.3 Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biologics CDMO Services Product Offered
11.17.3 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics CDMO Services Market Size (2021-2032)
2.1.2 Biologics CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biologics CDMO Services by Country/Region (2021, 2025 & 2032)
2.2 Biologics CDMO Services Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.2.5 Biologics CDMO Services Market Size by Type
2.2.5.1 Biologics CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biologics CDMO Services Market Size Market Share by Type (2021-2026)
2.3 Biologics CDMO Services Segment by Application
2.3.1 SMBs
2.3.2 Large Companies
2.3.3 Biologics CDMO Services Market Size by Application
2.3.3.1 Biologics CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Biologics CDMO Services Market Size Market Share by Application (2021-2026)
3 BIOLOGICS CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Biologics CDMO Services Market Size Market Share by Player
3.1.1 Global Biologics CDMO Services Revenue by Player (2021-2026)
3.1.2 Global Biologics CDMO Services Revenue Market Share by Player (2021-2026)
3.2 Global Biologics CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGICS CDMO SERVICES BY REGION
4.1 Biologics CDMO Services Market Size by Region (2021-2026)
4.2 Global Biologics CDMO Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biologics CDMO Services Market Size Growth (2021-2026)
4.4 APAC Biologics CDMO Services Market Size Growth (2021-2026)
4.5 Europe Biologics CDMO Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biologics CDMO Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biologics CDMO Services Market Size by Country (2021-2026)
5.2 Americas Biologics CDMO Services Market Size by Type (2021-2026)
5.3 Americas Biologics CDMO Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics CDMO Services Market Size by Region (2021-2026)
6.2 APAC Biologics CDMO Services Market Size by Type (2021-2026)
6.3 APAC Biologics CDMO Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologics CDMO Services Market Size by Country (2021-2026)
7.2 Europe Biologics CDMO Services Market Size by Type (2021-2026)
7.3 Europe Biologics CDMO Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics CDMO Services by Region (2021-2026)
8.2 Middle East & Africa Biologics CDMO Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biologics CDMO Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGICS CDMO SERVICES MARKET FORECAST
10.1 Global Biologics CDMO Services Forecast by Region (2027-2032)
10.1.1 Global Biologics CDMO Services Forecast by Region (2027-2032)
10.1.2 Americas Biologics CDMO Services Forecast
10.1.3 APAC Biologics CDMO Services Forecast
10.1.4 Europe Biologics CDMO Services Forecast
10.1.5 Middle East & Africa Biologics CDMO Services Forecast
10.2 Americas Biologics CDMO Services Forecast by Country (2027-2032)
10.2.1 United States Market Biologics CDMO Services Forecast
10.2.2 Canada Market Biologics CDMO Services Forecast
10.2.3 Mexico Market Biologics CDMO Services Forecast
10.2.4 Brazil Market Biologics CDMO Services Forecast
10.3 APAC Biologics CDMO Services Forecast by Region (2027-2032)
10.3.1 China Biologics CDMO Services Market Forecast
10.3.2 Japan Market Biologics CDMO Services Forecast
10.3.3 Korea Market Biologics CDMO Services Forecast
10.3.4 Southeast Asia Market Biologics CDMO Services Forecast
10.3.5 India Market Biologics CDMO Services Forecast
10.3.6 Australia Market Biologics CDMO Services Forecast
10.4 Europe Biologics CDMO Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biologics CDMO Services Forecast
10.4.2 France Market Biologics CDMO Services Forecast
10.4.3 UK Market Biologics CDMO Services Forecast
10.4.4 Italy Market Biologics CDMO Services Forecast
10.4.5 Russia Market Biologics CDMO Services Forecast
10.5 Middle East & Africa Biologics CDMO Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biologics CDMO Services Forecast
10.5.2 South Africa Market Biologics CDMO Services Forecast
10.5.3 Israel Market Biologics CDMO Services Forecast
10.5.4 Turkey Market Biologics CDMO Services Forecast
10.6 Global Biologics CDMO Services Forecast by Type (2027-2032)
10.7 Global Biologics CDMO Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biologics CDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biologics CDMO Services Product Offered
11.1.3 Lonza Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biologics CDMO Services Product Offered
11.2.3 Catalent Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biologics CDMO Services Product Offered
11.3.3 Samsung Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biologics CDMO Services Product Offered
11.5.3 Boehringer Ingelheim Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Biologics CDMO Services Product Offered
11.6.3 WuXi Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biologics CDMO Services Product Offered
11.7.3 Recipharm Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biologics CDMO Services Product Offered
11.8.3 Thermo Fisher Scientific Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biologics CDMO Services Product Offered
11.9.3 AGC Biologics Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biologics CDMO Services Product Offered
11.10.3 Rentschler Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biologics CDMO Services Product Offered
11.11.3 KBI Biopharma Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biologics CDMO Services Product Offered
11.12.3 Siegfried Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biologics CDMO Services Product Offered
11.13.3 Aenova Group Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biologics CDMO Services Product Offered
11.14.3 GenScript Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biologics CDMO Services Product Offered
11.15.3 ProBioGen Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biologics CDMO Services Product Offered
11.16.3 Northway Biotech Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biologics CDMO Services Product Offered
11.17.3 3P Biopharmaceuticals Biologics CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biologics CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biologics CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Table 10. Biologics CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Table 13. Global Biologics CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biologics CDMO Services Revenue Market Share by Player (2021-2026)
Table 15. Biologics CDMO Services Key Players Head office and Products Offered
Table 16. Biologics CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Table 21. Global Biologics CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biologics CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biologics CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biologics CDMO Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biologics CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biologics CDMO Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biologics CDMO Services
Table 41. Key Market Challenges & Risks of Biologics CDMO Services
Table 42. Key Industry Trends of Biologics CDMO Services
Table 43. Global Biologics CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biologics CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biologics CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biologics CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 48. Lonza Biologics CDMO Services Product Offered
Table 49. Lonza Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 53. Catalent Biologics CDMO Services Product Offered
Table 54. Catalent Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 58. Samsung Biologics Biologics CDMO Services Product Offered
Table 59. Samsung Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biologics CDMO Services Product Offered
Table 69. Boehringer Ingelheim Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 73. WuXi Biologics Biologics CDMO Services Product Offered
Table 74. WuXi Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi Biologics Main Business
Table 76. WuXi Biologics Latest Developments
Table 77. Recipharm Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 78. Recipharm Biologics CDMO Services Product Offered
Table 79. Recipharm Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biologics CDMO Services Product Offered
Table 84. Thermo Fisher Scientific Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 88. AGC Biologics Biologics CDMO Services Product Offered
Table 89. AGC Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 93. Rentschler Biopharma Biologics CDMO Services Product Offered
Table 94. Rentschler Biopharma Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 98. KBI Biopharma Biologics CDMO Services Product Offered
Table 99. KBI Biopharma Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 103. Siegfried Biologics CDMO Services Product Offered
Table 104. Siegfried Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 108. Aenova Group Biologics CDMO Services Product Offered
Table 109. Aenova Group Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 113. GenScript Biologics CDMO Services Product Offered
Table 114. GenScript Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 118. ProBioGen Biologics CDMO Services Product Offered
Table 119. ProBioGen Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 123. Northway Biotech Biologics CDMO Services Product Offered
Table 124. Northway Biotech Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biologics CDMO Services Product Offered
Table 129. 3P Biopharmaceuticals Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
Table 1. Biologics CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biologics CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biologics CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Table 10. Biologics CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Table 13. Global Biologics CDMO Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biologics CDMO Services Revenue Market Share by Player (2021-2026)
Table 15. Biologics CDMO Services Key Players Head office and Products Offered
Table 16. Biologics CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Table 21. Global Biologics CDMO Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biologics CDMO Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biologics CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biologics CDMO Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biologics CDMO Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biologics CDMO Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biologics CDMO Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biologics CDMO Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biologics CDMO Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biologics CDMO Services
Table 41. Key Market Challenges & Risks of Biologics CDMO Services
Table 42. Key Industry Trends of Biologics CDMO Services
Table 43. Global Biologics CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biologics CDMO Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biologics CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biologics CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 48. Lonza Biologics CDMO Services Product Offered
Table 49. Lonza Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 53. Catalent Biologics CDMO Services Product Offered
Table 54. Catalent Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 58. Samsung Biologics Biologics CDMO Services Product Offered
Table 59. Samsung Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biologics CDMO Services Product Offered
Table 69. Boehringer Ingelheim Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 73. WuXi Biologics Biologics CDMO Services Product Offered
Table 74. WuXi Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi Biologics Main Business
Table 76. WuXi Biologics Latest Developments
Table 77. Recipharm Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 78. Recipharm Biologics CDMO Services Product Offered
Table 79. Recipharm Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biologics CDMO Services Product Offered
Table 84. Thermo Fisher Scientific Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 88. AGC Biologics Biologics CDMO Services Product Offered
Table 89. AGC Biologics Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 93. Rentschler Biopharma Biologics CDMO Services Product Offered
Table 94. Rentschler Biopharma Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 98. KBI Biopharma Biologics CDMO Services Product Offered
Table 99. KBI Biopharma Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 103. Siegfried Biologics CDMO Services Product Offered
Table 104. Siegfried Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 108. Aenova Group Biologics CDMO Services Product Offered
Table 109. Aenova Group Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 113. GenScript Biologics CDMO Services Product Offered
Table 114. GenScript Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 118. ProBioGen Biologics CDMO Services Product Offered
Table 119. ProBioGen Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 123. Northway Biotech Biologics CDMO Services Product Offered
Table 124. Northway Biotech Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biologics CDMO Services Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biologics CDMO Services Product Offered
Table 129. 3P Biopharmaceuticals Biologics CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Biologics CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biologics CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biologics CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Biologics CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biologics CDMO Services Market Size Market Share by Type in 2025
Figure 10. Biologics CDMO Services in SMBs
Figure 11. Global Biologics CDMO Services Market: SMBs (2021-2026) & ($ millions)
Figure 12. Biologics CDMO Services in Large Companies
Figure 13. Global Biologics CDMO Services Market: Large Companies (2021-2026) & ($ millions)
Figure 14. Global Biologics CDMO Services Market Size Market Share by Application in 2025
Figure 15. Global Biologics CDMO Services Revenue Market Share by Player in 2025
Figure 16. Global Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Figure 17. Americas Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 18. APAC Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 19. Europe Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Americas Biologics CDMO Services Value Market Share by Country in 2025
Figure 22. United States Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Biologics CDMO Services Market Size Market Share by Region in 2025
Figure 27. APAC Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 28. APAC Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 29. China Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. India Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Biologics CDMO Services Market Size Market Share by Country in 2025
Figure 36. Europe Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 37. Europe Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 38. Germany Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 39. France Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 52. APAC Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 53. Europe Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. United States Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Canada Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. Mexico Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Brazil Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. China Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Japan Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. Korea Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. India Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Australia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. Germany Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. France Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. UK Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. Italy Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. Russia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Egypt Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. South Africa Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Israel Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. Turkey Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Global Biologics CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Biologics CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 1. Biologics CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics CDMO Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biologics CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biologics CDMO Services Sales Market Share by Country/Region (2025)
Figure 8. Biologics CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biologics CDMO Services Market Size Market Share by Type in 2025
Figure 10. Biologics CDMO Services in SMBs
Figure 11. Global Biologics CDMO Services Market: SMBs (2021-2026) & ($ millions)
Figure 12. Biologics CDMO Services in Large Companies
Figure 13. Global Biologics CDMO Services Market: Large Companies (2021-2026) & ($ millions)
Figure 14. Global Biologics CDMO Services Market Size Market Share by Application in 2025
Figure 15. Global Biologics CDMO Services Revenue Market Share by Player in 2025
Figure 16. Global Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Figure 17. Americas Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 18. APAC Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 19. Europe Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Biologics CDMO Services Market Size 2021-2026 ($ millions)
Figure 21. Americas Biologics CDMO Services Value Market Share by Country in 2025
Figure 22. United States Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Biologics CDMO Services Market Size Market Share by Region in 2025
Figure 27. APAC Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 28. APAC Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 29. China Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 33. India Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Biologics CDMO Services Market Size Market Share by Country in 2025
Figure 36. Europe Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 37. Europe Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 38. Germany Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 39. France Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Biologics CDMO Services Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Biologics CDMO Services Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Biologics CDMO Services Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Biologics CDMO Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 52. APAC Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 53. Europe Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 55. United States Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 56. Canada Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 57. Mexico Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 58. Brazil Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 59. China Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 60. Japan Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 61. Korea Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 63. India Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 64. Australia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 65. Germany Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 66. France Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 67. UK Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 68. Italy Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 69. Russia Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 70. Egypt Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 71. South Africa Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 72. Israel Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 73. Turkey Biologics CDMO Services Market Size 2027-2032 ($ millions)
Figure 74. Global Biologics CDMO Services Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Biologics CDMO Services Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Biologics CDMO Services Market Size 2027-2032 ($ millions)
